Apollo Endosurgery said today it closed its recently announced public offering, raising $36 million.
In the offering, the Austin, Texas-based company floated 6.5 million shares of common stock, including 853,363 from a fully exercised underwriter’s option for additional shares, at $5.50 per share.
Craig-Hallum Capital Group and Roth Capital Partners acted as book-runners for the offering, the company said in a press release.
Apollo Endosurgery has not yet stated how it plans to spend funds raised during the offering.
Last December, Apollo Endosurgery said it closed a reverse merger with Lpath (NSDQ:LPTN) in which Apollo put another $29 million into the combined company.